You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Unresectable Breast Carcinoma

Showing 9951 - 9975 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Aromatase Inhibitors Trial in Montpellier, Nîmes (Whole-body cryotherapy, Placebo cryotherapy)

Not yet recruiting
  • Breast Cancer
  • Aromatase Inhibitors
  • Whole-body cryotherapy
  • Placebo cryotherapy
  • Montpellier, France
  • +1 more
Jul 28, 2022

Urothelial Bladder Cancer, Gastric Adenocarcinoma, Gastro-oesophageal Adenocarcinoma Trial (Dostarlimab, Niraparib)

Not yet recruiting
  • Urothelial Bladder Cancer
  • +6 more
  • (no location specified)
Feb 26, 2021

Breast Cancer, Breast Tumors, Breast Cancer Female Trial (Soy isoflavones, Lignans, Placebo)

Withdrawn
  • Breast Cancer
  • +2 more
  • Soy isoflavones
  • +2 more
  • (no location specified)
May 10, 2021

Hepatocellular Carcinoma Trial in Guangzhou, Kaiping (HAIC of FOLFOX, Sorafenib)

Unknown status
  • Hepatocellular Carcinoma
  • Guangzhou, Guangdong, China
  • +2 more
Dec 3, 2020

Lymphocytic Leukemia, Chronic Trial in Worldwide (Chlorambucil, Venetoclax, Obinutuzumab)

Active, not recruiting
Has Results
  • Lymphocytic Leukemia, Chronic
  • Duarte, California
  • +136 more
Dec 22, 2022

SARS-COV2 (COVID-19) Persistence After Convalescence

Recruiting
  • COVID-19
  • +2 more
    • New York, New York
      Columbia University Medical Center
    Jul 19, 2022

    Peripheral Arterial Disease Trial in Worldwide (Stellarex 0.035" Over-the-Wire (OTW) drug-coated angioplasty balloon (Stellarex

    Active, not recruiting
    Has Results
    • Peripheral Arterial Disease
    • Stellarex 0.035" Over-the-Wire (OTW) drug-coated angioplasty balloon (Stellarex DCB)
    • Auchenflower, Australia
    • +43 more
    Mar 14, 2022

    Triple Negative Breast Cancer Trial in Guangzhou (Epalrestat)

    Terminated
    • Triple Negative Breast Cancer
    • Guangzhou, Guangdong, China
      Sun Yat-sen University, Cancer Center
    Jan 26, 2021

    Adjuvant Chemotherapy With Epirubicin, CMF, and Weekly Docetaxel

    Completed
    • Breast Cancer
    • Adenocarcinoma of Breast
      • (no location specified)
      Apr 2, 2021

      Lymphedema Trial in Nijmegen, Maastricht (Lymphaticovenous anastomosis (LVA))

      Recruiting
      • Lymphedema
      • Lymphaticovenous anastomosis (LVA)
      • Nijmegen, Gelderland, Netherlands
      • +1 more
      Sep 3, 2021

      Prostate Cancer, Breast Cancer, NSCLC Trial in Australia, United Kingdom (SBRT, Standard of Care)

      Active, not recruiting
      • Prostate Cancer
      • +2 more
      • SBRT
      • Standard of Care
      • Liverpool, New South Wales, Australia
      • +29 more
      Aug 20, 2019

      ArTificial inTelligence-based RAdiogenomics in Colon Tumors

      Recruiting
      • Colon Cancer Stage II
      • Colon Cancer Stage III
        • Roma, RM, Italy
          AOU Sant'Andrea
        Oct 24, 2023

        Breast Cancer Trial (Removal of axillary lymph nodes., Preservation of axillary lymph nodes)

        Active, not recruiting
        • Breast Cancer
        • Removal of axillary lymph nodes.
        • Preservation of axillary lymph nodes
        • (no location specified)
        Dec 16, 2021

        Breast Cancer Trial in Japan (Paclitaxel)

        Completed
        Has Results
        • Breast Cancer
        • Nagoya, Aichi, Japan
        • +3 more
        May 3, 2021

        Solid Tumor Trial in United States (BNT152, BNT153)

        Recruiting
        • Solid Tumor
        • New Haven, Connecticut
        • +3 more
        Sep 8, 2021

        Liver Cancer Trial in Baltimore (biological, drug, procedure)

        Completed
        Has Results
        • Liver Cancer
        • bevacizumab
        • +3 more
        • Baltimore, Maryland
          Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
        Aug 11, 2021

        Healthy Lactating Women Trial in Brussels (pregabalin (Lyrica))

        Completed
        Has Results
        • Healthy Lactating Women
        • pregabalin (Lyrica)
        • Brussels, Belgium
          Pfizer Clinical Research Unit
        Jan 26, 2021

        Physical Activity Program in Overweight Breast Cancer Patients

        Completed
        • Breast Cancer
        • Physical activity
        • Assen, Netherlands
        • +3 more
        Feb 1, 2021

        Advanced Cancer, Cervical Cancer, Triple Negative Breast Cancer Trial in Sutton (ASTX660, Pembrolizumab)

        Recruiting
        • Advanced Cancer
        • +2 more
        • Sutton, United Kingdom
          Royal Marden NHS Foundation Trust
        May 25, 2022

        Infant, Very Low Birth Weight, Lactation Trial in Winston-Salem (Instructional digital video disc (DVD))

        Completed
        • Infant, Very Low Birth Weight
        • Lactation
        • Instructional digital video disc (DVD)
        • Winston-Salem, North Carolina
          Forsyth Medical Center
        Oct 27, 2020

        Breast Cancer Trial in Worldwide (Tesetaxel, Capecitabine)

        Terminated
        • Breast Cancer
        • Whittier, California
        • +24 more
        Jul 26, 2021

        Lung Adenocarcinoma, Lung Large Cell Carcinoma, Resectable Lung Non-Small Cell Carcinoma Trial in Guam, Puerto Rico, United

        Recruiting
        • Lung Adenocarcinoma
        • +12 more
        • Birmingham, Alabama
        • +1612 more
        Aug 23, 2022

        Anal Cancer Trial in United States (biological, drug, radiation)

        Completed
        Has Results
        • Anal Cancer
        • cetuximab
        • +3 more
        • Stanford, California
        • +124 more
        Jun 8, 2022

        Urologic Tumors Trial in France, Italy, Spain (Afatinib)

        Completed
        Has Results
        • Urologic Neoplasms
        • Bordeaux, France
        • +29 more
        Oct 28, 2020

        Pleural Mesothelioma Malignant Advanced, Peritoneal Mesothelioma Malignant Advanced, Non-squamous Non-small Cell Lung Carcinoma

        Terminated
        • Pleural Mesothelioma Malignant Advanced
        • +6 more
        • ADI-PEG 20
        • Rochester, Minnesota
        • +3 more
        Sep 24, 2020